Printer Friendly

INAMED REPORTS RECORD NINE MONTH SALES AND PROFITS

    SANTA BARBARA, Calif., Nov. 16 ~PRNewswire~ -- Inamed Corporati on (NASDAQ: IMDC, PSE: INA), headquartered here, today reported record net income of $2,675,343, or 33 cents per share, for the first nine months of 1992.  This represents a 180 percent improvement on the net income of $954,489, or 12 cents per share, recorded for the first nine months if last year.  Record sales of $51,187,192, for the first nine months 1992 were a 64 percent improvement on sales of $31,182,890, recorded in the corresponding period of 1991.
    For the third quarter ended Sept. 30, 1992, the company reported net income of $426,595, or 5 cents per share, on sales of $13,019,971 compared to net income of $90,986, or 1 cent per share, on sales of $9,242,869 in the respective quarter of 1991.
    According to Inamed Chairman Donald K. McGhan, the company's strong sales growth in 1992 was achieved primarily through a reduction in the number of competitors and the company's ability to meet the market need for a high-quality line of saline-filled mammary implants.  The change in product focus from gel-filled to saline-filled implants resulted in gross profit margins of 67 percent for the first nine months of 1992 vs. 53 percent for the corresponding period of 1991.
    McGhan said expansion in European operations and higher costs associated with increases in regulatory activity in 1992 required "appropriate" increases in general and administrative expenses.  "To some extent, these increases were offset by a reduction in marketing costs."  Marketing expense as a percentage of net sales was 16 percent in the first nine months of 1992 vs. 21 percent in the first nine months of 1991.
    Inamed Corporation is a medical device company with 14 operating subsidiaries in the U.S. and Europe.  The company develops, manufactures and markets medical devices for the plastic and reconstructive, bariatric and general surgery markets.  The company reported sales of over $42.2 million for calendar~fiscal 1991.
                           INAMED CORPORATION
    Periods ended                Third Quarter           Nine Months
     Sept. 30                  1992       1991        1992        1991
    Sales                 $13,019,971 $9,242,869 $51,187,192 $31,182,890
    Income (loss) before
      income taxes            927,382   (349,999)  5,815,964   1,527,181
    Net income                426,595     90,986   2,675,343     954,489
    Profit pre share              .05        .01         .33         .12
    Weighted avg. shares
       outstanding          8,090,315  8,155,954   8,164,785   8,068,935
    -0-             11~16~92
    CONTACT:  Michael D. Farney, CEO of Inamed, 805-684-6277, or Jimmy Caplan, 805-569-0076, for Inamed
    (IMDC INA) CO:  INAMED IN:  MTC SU:  ERN ST:  CA


-- NY011 -- X118 11~16~92
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 16, 1992
Words:443
Previous Article:TELEKURS OPENS BOSTON OFFICE
Next Article:SOCIETE GENERALE SECURITIES AND HEALTHCARE CAPITAL GROUP SPONSORING AMERICAN BIOGENETIC SCIENCES PRESENTATION TO MEET NEW COMPANY PRESIDENT
Topics:


Related Articles
INAMED REPORTS THIRD QUARTER RESULTS
INAMED CORP. REPORTS RESULTS
INAMED CORPORATION TO BUY BACK SHARES
INAMED REPORTS RECORD SECOND QUARTER AND SIX-MONTH SALES AND PROFITS
INAMED REPORTS RECORD SALES FOR 1992
INAMED REPORTS RECORD SECOND QUARTER AND SIX MONTH PROFITS
INAMED REPORTS RECORD THIRD QUARTER RESULTS
INAMED CORP. REPORTS RECORD SALES FOR 1993; COMPANY TO TAKE LITIGATION SETTLEMENT ADJUSTMENT OF $9.15 MILLION
INAMED CORP. REPORTS SECOND QUARTER AND SIX MONTHS RESULTS
INAMED REPORTS TOTAL SALES FOR 2ND QTR HIGHEST EVER.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters